SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-029062
Filing Date
2014-05-09
Accepted
2014-05-09 16:07:54
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v376975_10q.htm 10-Q 216837
2 EX-31.1 v376975_ex31-1.htm EX-31.1 10405
3 EX-31.2 v376975_ex31-2.htm EX-31.2 10391
4 EX-32.1 v376975_ex32-1.htm EX-32.1 5004
5 EX-32.2 v376975_ex32-2.htm EX-32.2 4746
  Complete submission text file 0001144204-14-029062.txt   2385649

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20140331.xml EX-101.INS 252847
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20140331.xsd EX-101.SCH 30868
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20140331_cal.xml EX-101.CAL 27914
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20140331_def.xml EX-101.DEF 141956
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20140331_lab.xml EX-101.LAB 198696
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20140331_pre.xml EX-101.PRE 172068
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 14829115
SIC: 2836 Biological Products, (No Diagnostic Substances)